# US 2026/0096586 A1 · Compositions and methods for activating glp-1 secretion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0096586 A1
- Document ID: US20260096586A1
- Status: Published application
- Kind: A1
- Application number: 18/910,816
- Filed: 2024-10-09
- Published: 2026-04-09
- Earliest claimed: 2024-10-09
- Assignees: LifeVantage Corporation
- Applicants: LifeVantage Corporation
- Inventors: Elisa Diane BARNES; Christina Beer; Clinton T. Horton; Robert A. Carr
- Web page: https://patentgrep.com/patent/US20260096586A1

## CPC

- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23L 33/16: Inorganic salts, minerals or trace elements
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)

## Abstract

Nutritional supplements and compositions for activating the GLP-1 peptide and/or other hormones in a subject in order to regulate blood sugar, weight, and hunger of the subject are described in this application. The compositions include a first nutritional supplement containing specific amounts of hydrolyzed Acacia gum, lemon bioflavonoids, chromium, Berberis aristate, and hesperidin. The compositions also include a second nutritional supplement containing specific amounts of flax seed oil, resistant potato starch, resistant tapioca fiber, kombucha, Bacillus coagulans, Bacillus clausii, and allulose. A third composition includes the first and second nutritional supplements containing these ingredients in sufficient amounts to regulate the GLP-1 peptide and/or other hormones. These compositions are able to increase the GLP-1 concentration in the blood by up to about 140% without binding directly to any GLP-1 receptors. Other embodiments are also described.

## Claims

### Claim 1

A nutritional supplement composition, comprising:
about 8.14 to about 78.01 wt % hydrolyzed acacia gum;
about 3.54 to about 26.83 wt % lemon bioflavonoids;
about 0.007 to about 0.171 wt % chromium;
about 3.41 to about 26.09 wt % Berberis aristate; and
about 3.69 to about 43.35 wt % hesperidin.

### Claim 2 (depends on 1)

The composition of claim 1 containing about 64 wt % hydrolyzed acacia gum.

### Claim 3 (depends on 1)

The composition of claim 1 containing about 12.8 wt % lemon bioflavonoids.

### Claim 4 (depends on 1)

The composition of claim 1 containing about 0.14 wt % chromium.

### Claim 5 (depends on 1)

The composition of claim 1 containing about 6.6 wt % Berberis aristate

### Claim 6 (depends on 1)

The composition of claim 1 containing about 7.1 wt % hesperidin.

### Claim 7

A nutritional supplement composition, comprising:
about 2.497 to about 17.00 wt % flax seed oil;
about 6.573 to about 51.35 wt % resistant potato starch;
about 6.573 to about 51.35 wt % resistant tapioca fiber;
about 0.023 to about 2.253 wt % kombucha;
about 0.013 to about 0.253 wt % Bacillus coagulans;
about 0.013 to about 0.253 wt % Bacillus clausii; and
about 0.939 to about 4.523 wt % allulose.

### Claim 8 (depends on 1)

The composition of claim 1 containing about 10.1 wt % flax seed oil.

### Claim 9 (depends on 1)

The composition of claim 1 containing about 34.6 wt % resistant potato starch.

### Claim 10 (depends on 1)

The composition of claim 1 containing about 34.6 wt % resistant tapioca fiber.

### Claim 11 (depends on 1)

The composition of claim 1 containing about 0.2 wt % kombucha.

### Claim 12 (depends on 1)

The composition of claim 1 containing about 0.025 wt % Bacillus coagulans.

### Claim 13 (depends on 1)

The composition of claim 1 containing about 0.025 wt % Bacillus clausii.

### Claim 14 (depends on 1)

The composition of claim 1 containing about 2.8 wt % allulose.

### Claim 15

A nutritional supplement, comprising:
about 1 to about 2 grams of a first composition comprising:
about 8.14 to about 78.01 wt % hydrolyzed acacia gum;
about 3.54 to about 26.83 wt % lemon bioflavonoids;
about 0.007 to about 0.171 wt % chromium;
about 3.41 to about 26.09 wt % Berberis aristate; and
about 3.69 to about 43.35 wt % hesperidin;
and about 5 to about 6 grams of a second composition comprising:
about 2.497 to about 17.00 wt % flax seed oil;
about 6.573 to about 51.35 wt % resistant potato starch;
about 6.573 to about 51.35 wt % resistant tapioca fiber;
about 0.23 to about 2.253 wt % kombucha;
about 0.013 to about 0.253 wt % Bacillus coagulans;
about 0.013 to about 0.253 wt % Bacillus clausii; and
about 0.939 to about 4.523 wt % allulose.

### Claim 16

A nutritional supplement, comprising:
about 5.2 wt % hydrolyzed acacia gum;
about 1.04 wt % lemon bioflavonoids;
about 0.001 wt % chromium;
about 0.52 wt % Berberis aristate;
about 0.52 wt % hesperidin;
about 11.4 wt % flax seed oil;
about 39 wt % resistant potato starch;
about 39 wt % resistant tapioca fiber;
about 0.1 wt % kombucha;
about 0.026 wt % Bacillus coagulans;
about 0.026 wt % Bacillus clausii; and
about 3.14 wt % allulose.

### Claim 17

A method of activating GLP-1 and other hormones by administering a nutritional supplement composition to an individual, comprising:
about 5.2 wt % hydrolyzed acacia gum;
about 1.04 wt % lemon bioflavonoids;
about 0.001 wt % chromium;
about 0.52 wt % Berberis aristate;
about 0.52 wt % hesperidin;
about 11.4 wt % flax seed oil;
about 39 wt % resistant potato starch;
about 39 wt % resistant tapioca fiber;
about 0.1 wt % kombucha;
about 0.026 wt % Bacillus coagulans;
about 0.026 wt % Bacillus clausii; and
about 3.14 wt % allulose.

### Claim 18 (depends on 17)

The method of claim 17, wherein the composition does not bind directly to the GLP-1 receptors.

### Claim 19 (depends on 17)

The method of claim 17, wherein the GLP-1 concentration in the blood is increased by up to about 140%.

### Claim 20 (depends on 17)

The method of claim 17, wherein administering the nutritional supplement composition to an individual resulted in a loss of body weight while maintaining or increasing the skeletal muscle.
